Psomagen, Inc. (KOSDAQ:950200)

Psomagen Statistics

Total Valuation

Psomagen has a market cap or net worth of KRW 69.44 billion. The enterprise value is 70.82 billion.

Market Cap	69.44B
Enterprise Value	70.82B

Important Dates

The next estimated earnings date is Friday, November 14, 2025.

Earnings Date	Nov 14, 2025
Ex-Dividend Date	n/a

Share Statistics

Psomagen has 19.24 million shares outstanding. The number of shares has increased by 11.33% in one year.

Current Share Class	n/a
Shares Outstanding	19.24M
Shares Change (YoY)	+11.33%
Shares Change (QoQ)	+4.38%
Owned by Insiders (%)	2.34%
Owned by Institutions (%)	n/a
Float	8.25M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.32
PB Ratio	2.78
P/TBV Ratio	3.52
P/FCF Ratio	478.06
P/OCF Ratio	18.99
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 60.64, with an EV/FCF ratio of 487.55.

EV / Earnings	-13.64
EV / Sales	1.35
EV / EBITDA	60.64
EV / EBIT	n/a
EV / FCF	487.55

Financial Position

The company has a current ratio of 1.52, with a Debt / Equity ratio of 0.50.

Current Ratio	1.52
Quick Ratio	1.03
Debt / Equity	0.50
Debt / EBITDA	9.12
Debt / FCF	86.08
Interest Coverage	-4.69

Financial Efficiency

Return on equity (ROE) is -21.64% and return on invested capital (ROIC) is -6.19%.

Return on Equity (ROE)	-21.64%
Return on Assets (ROA)	-4.88%
Return on Invested Capital (ROIC)	-6.19%
Return on Capital Employed (ROCE)	-11.55%
Revenue Per Employee	619.45M
Profits Per Employee	-61.08M
Employee Count	89
Asset Turnover	1.05
Inventory Turnover	7.10

Taxes

Income Tax	-26.81M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -15.75% in the last 52 weeks. The beta is 0.09, so Psomagen's price volatility has been lower than the market average.

Beta (5Y)	0.09
52-Week Price Change	-15.75%
50-Day Moving Average	3,792.90
200-Day Moving Average	3,826.43
Relative Strength Index (RSI)	32.56
Average Volume (20 Days)	15,628

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Psomagen had revenue of KRW 52.65 billion and -5.19 billion in losses. Loss per share was -262.92.

Revenue	52.65B
Gross Profit	11.98B
Operating Income	-3.90B
Pretax Income	-6.12B
Net Income	-5.19B
EBITDA	1.37B
EBIT	-3.90B
Loss Per Share	-262.92

Balance Sheet

The company has 10.13 billion in cash and 12.50 billion in debt, giving a net cash position of -2.37 billion or -123.17 per share.

Cash & Cash Equivalents	10.13B
Total Debt	12.50B
Net Cash	-2.37B
Net Cash Per Share	-123.17
Equity (Book Value)	24.99B
Book Value Per Share	1,350.54
Working Capital	8.37B

Cash Flow

In the last 12 months, operating cash flow was 3.66 billion and capital expenditures -3.51 billion, giving a free cash flow of 145.26 million.

Operating Cash Flow	3.66B
Capital Expenditures	-3.51B
Free Cash Flow	145.26M
FCF Per Share	7.55

Margins

Gross margin is 22.76%, with operating and profit margins of -7.41% and -9.86%.

Gross Margin	22.76%
Operating Margin	-7.41%
Pretax Margin	-11.62%
Profit Margin	-9.86%
EBITDA Margin	2.60%
EBIT Margin	-7.41%
FCF Margin	0.28%

Dividends & Yields

Psomagen does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-11.33%
Shareholder Yield	-11.33%
Earnings Yield	-7.48%
FCF Yield	0.21%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Psomagen has an Altman Z-Score of 0.54 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.54
Piotroski F-Score	3